Published in Manag Care Interface on April 01, 2004
Evaluating end-of-life opioid use in managed care plans. Manag Care Interface (2004) 0.75
Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13
Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2006) 5.86
Population-wide benefits of routine vaccination of children against influenza. Vaccine (2005) 2.68
Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints. Pain (2005) 2.62
Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis (2009) 2.41
Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med (2003) 2.39
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. Diabetes Care (2003) 2.29
Therapy switching in patients receiving long-acting opioids. Ann Pharmacother (2004) 2.14
Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model. Value Health (2004) 2.05
Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain (2004) 1.92
The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups. Int J Infect Dis (2008) 1.67
Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer (2006) 1.61
Is sepsis accurately coded on hospital bills? Value Health (2002) 1.60
Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother (2011) 1.58
Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. Am J Manag Care (2009) 1.52
Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Invest (2002) 1.49
The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Oncology (2004) 1.47
Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol (2008) 1.41
Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq. Vaccine (2009) 1.40
Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis. Pain (2003) 1.39
Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality. BMC Cancer (2011) 1.30
Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol (2006) 1.28
Randomized controlled trial of a computer-based, tailored intervention to increase smoking cessation counseling by primary care physicians. J Gen Intern Med (2007) 1.23
Economic costs of nonmedical use of prescription opioids. Clin J Pain (2011) 1.22
Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data. Am J Manag Care (2004) 1.17
Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization? Ann Pharmacother (2006) 1.15
Infliximab drug and infusion costs among patients with Crohn's disease in a commercially-insured setting. Am J Ther (2006) 1.13
Risk of venous thromboembolism among hospitalized medically ill patients. Am J Health Syst Pharm (2006) 1.12
Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study. Clin Ther (2008) 1.10
Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study. Clin Ther (2009) 1.10
Risk-factor clustering and cardiovascular disease risk in hypertensive patients. Am J Hypertens (2007) 1.10
Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surg Infect (Larchmt) (2008) 1.09
Resource utilization and costs before and after total joint arthroplasty. BMC Health Serv Res (2012) 1.06
The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer. Value Health (2002) 1.04
Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer (2006) 1.02
Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J Clin Microbiol (2010) 1.02
Clinical and economic consequences of bleeding following major orthopedic surgery. Thromb Res (2006) 1.01
Use of oral antithrombotic agents among health maintenance organization members with atherosclerotic cardiovascular disease. Arch Intern Med (2002) 1.01
Effectiveness of bisphosphonate therapy in a community setting. Bone (2008) 1.01
Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis. J Rheumatol (2011) 1.00
Dose intensification with infliximab in patients with rheumatoid arthritis. Ann Pharmacother (2005) 1.00
Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy. Am J Clin Oncol (2012) 0.99
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy. BMC Health Serv Res (2011) 0.98
Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. J Support Oncol (2007) 0.96
Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol (2009) 0.96
Adherence with migraine prophylaxis in clinical practice. Pain Pract (2012) 0.95
Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manag Care (2010) 0.92
Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis. Arthritis Rheum (2011) 0.91
Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonists. J Rheumatol (2008) 0.90
Blood pressure control in patients initiating antihypertensive therapy. Ann Pharmacother (2008) 0.89
Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. Curr Med Res Opin (2008) 0.88
Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer. J Thorac Oncol (2006) 0.88
Risperidone versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder : Symptoms, Quality of Life and Resource Use under Customary Clinical Care. Clin Drug Investig (2004) 0.87
Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumonia. J Hosp Med (2010) 0.87
Cost-effectiveness of tacrolimus ointment versus pimecrolimus cream in adults with atopic dermatitis. J Drugs Dermatol (2010) 0.86
Initial treatment failure in patients with complicated skin and skin structure infections. Surg Infect (Larchmt) (2013) 0.86
Comparative effectiveness of patient-centered strategies to improve FDA medication guides. Med Care (2014) 0.85
Patterns of initial antibiotic therapy for community-acquired pneumonia in U.S. hospitals, 2000 to 2009. Am J Med Sci (2014) 0.85
Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil. Curr Med Res Opin (2007) 0.85
Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation. Clin Ther (2008) 0.85
Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder. Ann Pharmacother (2012) 0.84
Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder. BMC Geriatr (2009) 0.84
Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study. BMC Neurol (2012) 0.84
The impact of seizures and adverse effects on global health ratings. Epilepsy Behav (2007) 0.84
Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER. Curr Med Res Opin (2008) 0.83
Treatment of peripheral neuropathic pain: a simulation model. Eur J Pain (2005) 0.83
Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study. BMC Pulm Med (2012) 0.83
Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients. Am J Health Syst Pharm (2002) 0.83
Identification of patients receiving peritoneal dialysis using health insurance claims data. Clin Ther (2009) 0.83
Clinical and economic characteristics of patients with painful neuropathic disorders in Germany. Pain Pract (2008) 0.82
7-Valent pneumococcal conjugate vaccine and lower respiratory tract infections: effectiveness of a 2-dose versus 3-dose primary series. Vaccine (2009) 0.82
Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy. Clin J Pain (2007) 0.82
Direct and indirect economic costs among private-sector employees with osteoarthritis. J Occup Environ Med (2011) 0.82
Excess risk of diabetes in persons with hypertension. J Diabetes Complications (2008) 0.82
Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study. BMC Psychiatry (2012) 0.82
Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged > or =65 years with rheumatoid arthritis. Clin Ther (2005) 0.81
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective. Eur J Health Econ (2009) 0.81
A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery. Pharmacoeconomics (2004) 0.80
Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy. Epilepsia (2007) 0.80
Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemia. Clin Ther (2008) 0.80
Utilization and cost in clinical practice of darbepoetin alfa and epoetin alfa for anemia concomitant with chemotherapy. Clin Ther (2012) 0.80
Identifying suboptimal management of persistent pain from integrated claims data: a feasibility study. Manag Care (2003) 0.79
Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage. Curr Med Res Opin (2009) 0.79
Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study. BMC Psychiatry (2011) 0.78
Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain? Eur J Pain (2008) 0.78
Solifenacin for overactive bladder: patient-reported outcomes from a large placebo-controlled trial. Postgrad Med (2009) 0.78
Automated Internet-based pain coping skills training to manage osteoarthritis pain: a randomized controlled trial. Pain (2015) 0.77
Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study. BMC Psychiatry (2012) 0.77
The impact of esophageal candidiasis on hospital charges and costs across patient subgroups. Curr Med Res Opin (2008) 0.77
Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K. Pain Pract (2008) 0.77
Fentanyl transdermal system and oxycodone hydrochloride. J Manag Care Pharm (2003) 0.77
Prophylaxis against venous thromboembolism in hospitalized medically ill patients. Circ Cardiovasc Qual Outcomes (2013) 0.77
Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia. Clin Ther (2003) 0.77
Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life. J Pain Symptom Manage (2003) 0.76